Sumatriptan Tablet
Product Images NDC 63187-931

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 63187-931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line graph showing the estimated probability of response over time in minutes from the initial dose for Sumatriptan at doses of 25 mg, 50 mg, 100 mg, and placebo. The graph depicts increased response probability with higher doses and over time up to 240 minutes.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)

A line graph showing the estimated probability of headache remission or rescue over 24 hours after initial dosing. The graph compares four groups: placebo, 25 mg, 50 mg, and 100 mg of sumatriptan, illustrating increasing efficacy with higher doses over time.*

FDA Label Image

63187-931-09 (Sumatriptan Fig5)

Label for Sumatriptan 100 mg tablets, a human prescription drug. The label shows the ProficientRx brand and indicates the product contains sumatriptan succinate USP equivalent to 100 mg sumatriptan per tablet. Tablets are described as white to off-white, capsule-shaped, biconvex, uncoated with 'C' on one side and '34' on the other. Manufacturer is Aurobindo Pharma Limited, India, with relabeling by Proficient Rx LP, Thousand Oaks, CA. Storage instructions and lot/expiration details are present.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure of the active ingredient Sumatriptan Succinate, showing the molecular components and bonding arrangement typical for this pharmaceutical compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.